Molecular signaling in pathogenesis of craniosynostosis: The role of fibroblast growth factor and transforming growth factor-β

Neurosurgical Focus

Volumn 31, Issue 2, 2011, Pages

  Chim, Harvey ^a   Manjila, Sunil ^b   Cohen, Alan R ^b   Gosain, Arun K ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Craniosynostosis; Fibroblast growth factor; Molecular signaling; Pathogenesis; Transforming growth factor beta

Indexed keywords

FIBROBLAST GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; CRANIOFACIAL SYNOSTOSIS; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CRANIOSYNOSTOSES; FIBROBLAST GROWTH FACTORS; HUMANS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 80052203175     PISSN: None     EISSN: 10920684     Source Type: Journal    
DOI: 10.3171/2011.5.FOCUS1197     Document Type: Article

References (61)

1. Agresti M, Gosain AK: Detection of apoptosis in fusing versus nonfusing mouse cranial sutures. J Craniofac Surg 16:572-578, 2005
2. Bourgeois P, Bolcato-Bellemin AL, Danse JM, Bloch-Zupan A, Yoshiba K, Stoetzel C, et al: The variable expressivity and incomplete penetrance of the twist-null heterozygous mouse phenotype resemble those of human Saethre-Chotzen syndrome. Hum Mol Genet 7:945-957, 1998
3. Brueton LA, van Herwerden L, Chotai KA, Winter RM: The mapping of a gene for craniosynostosis: evidence for linkage of the Saethre-Chotzen syndrome to distal chromosome 7p. J Med Genet 29:681-685, 1992
4. Chun K, Siegel-Bartelt J, Chitayat D, Phillips J, Ray PN: FGFR2 mutation associated with clinical manifestations consistent with Antley-Bixler syndrome. Am J Med Genet 77: 219-224, 1998
5. Davidson D: The function and evolution of Msx genes: pointers and paradoxes. Trends Genet 11:405-411, 1995
6. de Caestecker M: The transforming growth factor-beta superfamily of receptors. Cytokine Growth Factor Rev 15:1-11, 2004
7. Delezoide AL, Benoist-Lasselin C, Legeai-Mallet L, Le Merrer M, Munnich A, Vekemans M, et al: Spatio-temporal expression of FGFR 1, 2 and 3 genes during human embryo-fetal ossification. Mech Dev 77:19-30, 1998
8. Gaudenz K, Roessler E, Vainikka S, Alitalo K, Muenke M: Analysis of patients with craniosynostosis syndromes for a pro246Arg mutation of FGFR4. Mol Genet Metab 64:76-79, 1998
9. Glaser RL, Jiang W, Boyadjiev SA, Tran AK, Zachary AA, Van Maldergem L, et al: Paternal origin of FGFR2 mutations in sporadic cases of Crouzon syndrome and Pfeiffer syndrome. Am J Hum Genet 66:768-777, 2000
10. Gosain AK, Machol JA IV, Gliniak C, Halligan NL: TGF-β1 RNA interference in mouse primary dura cell culture: downstream effects on TGF receptors, FGF-2, and FGF-R1 mRNA levels. Plast Reconstr Surg 124:1466-1473, 2009
11. Gosain AK, Recinos RF, Agresti M, Khanna AK: TGF-β1, FGF-2, and receptor mRNA expression in suture mesenchyme and dura versus underlying brain in fusing and nonfusing mouse cranial sutures. Plast Reconstr Surg 113:1675-1684, 2004
12. Gupta AK, Eshraghi Y, Gliniak C, Gosain AK: Nonviral transfection of mouse calvarial organ in vitro using Accellmodified siRNA. Plast Reconstr Surg 125:494-501, 2010
13. Hamamori Y, Sartorelli V, Ogryzko V, Puri PL, Wu HY, Wang JY, et al: Regulation of histone acetyltransferases p300 and PCAF by the bHLH protein twist and adenoviral oncoprotein E1A. Cell 96:405-413, 1999
14. Harada SL, Rodan GA: Control of osteoblast function and regulation of bone mass. Nature 423:349-355, 2003
15. Hatch NE: Potential role of PC-1 expression and pyrophosphate elaboration in the molecular etiology of the FGFR-associated craniosynostosis syndromes. Orthod Craniofac Res 10:53-58, 2007
16. Ibrahimi OA, Zhang F, Eliseenkova AV, Linhardt RJ, Mohammadi M: Proline to arginine mutations in FGF receptors 1 and 3 result in Pfeiffer and Muenke craniosynostosis syndromes through enhancement of FGF binding affinity. Hum Mol Genet 13:69-78, 2004
17. Igarashi M, Finch PW, Aaronson SA: Characterization of recombinant human fibroblast growth factor (FGF)-10 reveals functional similarities with keratinocyte growth factor (FGF-7). J Biol Chem 273:13230-13235, 1998
18. Iseki S, Wilkie AO, Morriss-Kay GM: Fgfr1 and Fgfr2 have distinct differentiation- and proliferation-related roles in the developing mouse skull vault. Development 126:5611-5620, 1999
19. Kan SH, Elanko N, Johnson D, Cornejo-Roldan L, Cook J, Reich EW, et al: Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis. Am J Hum Genet 70:472-486, 2002
20. Lee SW, Choi KY, Cho JY, Jung SH, Song KB, Park EK, et al: TGF-beta2 stimulates cranial suture closure through activation of the Erk-MAPK pathway. J Cell Biochem 98:981-991, 2006
21. Liu YH, Tang Z, Kundu RK, Wu L, Luo W, Zhu D, et al: Msx2 gene dosage influences the number of proliferative osteogenic cells in growth centers of the developing murine skull: a possible mechanism for MSX2-mediated craniosynostosis in humans. Dev Biol 205:260-274, 1999
22. Lomri A, Lemonnier J, Hott M, de Parseval N, Lajeunie E, Munnich A, et al: Increased calvaria cell differentiation and bone matrix formation induced by fibroblast growth factor receptor 2 mutations in Apert syndrome. J Clin Invest 101:1310-1317, 1998
23. Longo KA, Kennell JA, Ochocinska MJ, Ross SE, Wright WS, MacDougald OA: Wnt signaling protects 3T3-L1 preadipocytes from apoptosis through induction of insulin-like growth factors. J Biol Chem 277:38239-38244, 2002
24. Mansukhani A, Ambrosetti D, Holmes G, Cornivelli L, Basilico C: Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation. J Cell Biol 168:1065-1076, 2005
25. Mansukhani A, Bellosta P, Sahni M, Basilico C: Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts. J Cell Biol 149:1297-1308, 2000
26. Mathy JA, Lenton K, Nacamuli RP, Fong KD, Song HM, Fang TD, et al: FGF-2 stimulation affects calvarial osteoblast biology: quantitative analysis of nine genes important for cranial suture biology by real-time reverse transcription polymerase chain reaction. Plast Reconstr Surg 112:528-539, 2003
27. Meyers GA, Day D, Goldberg R, Daentl DL, Przylepa KA, Abrams LJ, et al: FGFR2 exon IIIa and IIIc mutations in Crouzon, Jackson-Weiss, and Pfeiffer syndromes: evidence for missense changes, insertions, and a deletion due to alternative RNA splicing. Am J Hum Genet 58:491-498, 1996
28. Meyers GA, Orlow SJ, Munro IR, Przylepa KA, Jabs EW: Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans. Nat Genet 11:462-464, 1995
29. Miraoui H, Ringe J, Häupl T, Marie PJ: Increased EFG- and PDGFalpha-receptor signaling by mutant FGF-receptor 2 contributes to osteoblast dysfunction in Apert craniosynostosis. Hum Mol Genet 19:1678-1689, 2010
30. Moloney DM, Slaney SF, Oldridge M, Wall SA, Sahlin P, Stenman G, et al: Exclusive paternal origin of new mutations in Apert syndrome. Nat Genet 13:48-53, 1996
31. Moloney DM, Wall SA, Ashworth GJ, Oldridge M, Glass IA, Francomano CA, et al: Prevalence of Pro250Arg mutation of fibroblast growth factor receptor 3 in coronal craniosynostosis. Lancet 349:1059-1062, 1997
32. Mooney MP, Losken HW, Moursi AM, Bradley J, Azari K, Acarturk TO, et al: Anti-TGF-beta2 antibody therapy inhibits postoperative resynostosis in craniosynostotic rabbits. Plast Reconstr Surg 119:1200-1215, 2007
33. Mooney MP, Losken HW, Moursi AM, Shand JM, Cooper GM, Curry C, et al: Postoperative anti-Tgf-beta2 antibody therapy improves intracranial volume and craniofacial growth in craniosynostotic rabbits. J Craniofac Surg 18:336-349, 2007
34. Most D, Levine JP, Chang J, Sung J, McCarthy JG, Schendel SA, et al: Studies in cranial suture biology: up-regulation of transforming growth factor-beta1 and basic fibroblast growth factor mRNA correlates with posterior frontal cranial suture fusion in the rat. Plast Reconstr Surg 101:1431-1440, 1998
35. Muenke M, Gripp KW, McDonald-McGinn DM, Gaudenz K, Whitaker LA, Bartlett SP, et al: A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome. Am J Hum Genet 60:555-564, 1997
36. Muenke M, Schell U: Fibroblast-growth-factor receptor mutations in human skeletal disorders. Trends Genet 11:303-313, 1995
37. Muenke M, Schell U, Hehr A, Robin NH, Losken HW, Schinzel A, et al: A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nat Genet 8:269-274, 1994
38. Opperman LA: Cranial sutures as intramembranous bone growth sites. Dev Dyn 219:472-485, 2000
39. Opperman LA, Fernandez CR, So S, Rawlins JT: Erk1/2 signaling is required for Tgf-beta 2-induced suture closure. Dev Dyn 235:1292-1299, 2006
40. Opperman LA, Galanis V, Williams AR, Adab K: Transforming growth factor-beta3 (Tgf-beta3) down-regulates Tgf-beta3 receptor type I (Tbetar-I) during rescue of cranial sutures from osseous obliteration. Orthod Craniofac Res 5:5-16, 2002
41. Opperman LA, Nolen AA, Ogle RC: TGF-beta 1, TGF-beta 2, and TGF-beta 3 exhibit distinct patterns of expression during cranial suture formation and obliteration in vivo and in vitro. J Bone Miner Res 12:301-310, 1997
42. Opperman LA, Passarelli RW, Morgan EP, Reintjes M, Ogle RC: Cranial sutures require tissue interactions with dura mater to resist osseous obliteration in vitro. J Bone Miner Res 10:1978-1987, 1995
43. Ornitz DM, Xu J, Colvin JS, McEwen DG, MacArthur CA, Coulier F, et al: Receptor specificity of the fibroblast growth factor family. J Biol Chem 271:15292-15297, 1996
44. Poisson E, Sciote JJ, Koepsel R, Cooper GM, Opperman LA, Mooney MP: Transforming growth factor-beta isoform expression in the perisutural tissues of craniosynostotic rabbits. Cleft Palate Craniofac J 41:392-402, 2004
45. Preston RA, Post JC, Keats BJ, Aston CE, Ferrell RE, Priest J, et al: A gene for Crouzon craniofacial dysostosis maps to the long arm of chromosome 10. Nat Genet 7:149-153, 1994
46. Przylepa KA, Paznekas W, Zhang M, Golabi M, Bias W, Bamshad MJ, et al: Fibroblast growth factor receptor 2 mutations in Beare-Stevenson cutis gyrata syndrome. Nat Genet 13:492-494, 1996
47. Reardon W, Winter RM, Rutland P, Pulleyn LJ, Jones BM, Malcolm S: Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nat Genet 8:98-103, 1994
48. Roth DA, Longaker MT, McCarthy JG, Rosen DM, McMullen HF, Levine JP, et al: Studies in cranial suture biology: Part I. Increased immunoreactivity for TGF-beta isoforms (beta 1, beta 2, and beta 3) during rat cranial suture fusion. J Bone Miner Res 12:311-321, 1997
49. Rutland P, Pulleyn LJ, Reardon W, Baraitser M, Hayward R, Jones B, et al: Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes. Nat Genet 9:173-176, 1995
50. Sanford LP, Ormsby I, Gittenberger-de Groot AC, Sariola H, Friedman R, Boivin GP, et al: TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development 124:2659-2670, 1997
51. Schell U, Hehr A, Feldman GJ, Robin NH, Zackai EH, de Die-Smulders C, et al: Mutations in FGFR1 and FGFR2 cause familial and sporadic Pfeiffer syndrome. Hum Mol Genet 4: 323-328, 1995
52. Smartt JM Jr, Karmacharya J, Gannon FH, Teixeira C, Mansfield K, Hunenko O, et al: Intrauterine fetal constraint induces chondrocyte apoptosis and premature ossification of the cranial base. Plast Reconstr Surg 116:1363-1369, 2005
53. Steinberger D, Mulliken JB, Müller U: Predisposition for cysteine substitutions in the immunoglobulin-like chain of FGFR2 in Crouzon syndrome. Hum Genet 96:113-115, 1995
54. Tickle C: Worlds in common through NF-kappaB. Nature 392:547-549, 1998
55. Warren SM, Brunet LJ, Harland RM, Economides AN, Longaker MT: The BMP antagonist noggin regulates cranial suture fusion. Nature 422:625-629, 2003
56. Webster MK, Donoghue DJ: FGFR activation in skeletal disorders: too much of a good thing. Trends Genet 13:178-182, 1997
57. Wilkie AO, Slaney SF, Oldridge M, Poole MD, Ashworth GJ, Hockley AD, et al: Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nat Genet 9:165-172, 1995
58. Yousfi M, Lasmoles F, El Ghouzzi V, Marie PJ: Twist haploinsufficiency in Saethre-Chotzen syndrome induces calvarial osteoblast apoptosis due to increased TNFalpha expression and caspase-2 activation. Hum Mol Genet 11:359-369, 2002
59. Yu K, Herr AB, Waksman G, Ornitz DM: Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome. Proc Natl Acad Sci U S A 97:14536-14541, 2000
60. Yu P, Gosain AK, Khanna A: The role of transforming growth factor-beta in the modulation of mouse cranial suture fusion. Plast Reconstr Surg 108:916-926, 2001
61. Zorn AM, Barish GD, Williams BO, Lavender P, Klymkowsky MW, Varmus HE: Regulation of Wnt signaling by Sox proteins: XSox17 α/β and XSox3 physically interact with β-catenin. Mol Cell 4:487-498, 1999